Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Key Documents

View All Documentation

I9885

Sigma-Aldrich

Anti-Human IgG (γ-chain specific), F(ab′)2 fragment antibody produced in goat

affinity isolated antibody, lyophilized powder

Synonim(y):

Goat Anti-Human IgG

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(1)

About This Item

Numer MDL:
MFCD00162442
Kod UNSPSC:
12352203
NACRES:
NA.46

pochodzenie biologiczne

goat

Poziom jakości

200

białko sprzężone

unconjugated

forma przeciwciała

affinity isolated antibody

rodzaj przeciwciała

secondary antibodies

klon

polyclonal

Postać

lyophilized powder

opakowanie

pkg of 5x1 mg
pkg of 1 mg

warunki przechowywania

avoid repeated freeze/thaw cycles

metody

Ouchterlony double diffusion: suitable
quantitative precipitin assay: suitable

kolor

white to off-white

rozpuszczalność

water: soluble, clear to hazy, colorless (after reconstitution with 1 ml of 0.135 M NaCl)

temp. przechowywania

2-8°C

docelowa modyfikacja potranslacyjna

unmodified

Powiązane kategorie

Opis ogólny

IgG antibody subtype is the most abundant serum immunoglobulins of the immune system. It is secreted by B cells and is found in blood and extracellular fluids and provides protection from infections caused by bacteria, fungi and viruses. Maternal IgG is transferred to fetus through the placenta that is vital for immune defence of the neonate against infections. Anti-Human IgG (γ-chain specific), F(ab′)2 fragment antibody is specific for human IgG subclasses. The F(ab′)2 fragment of the antibody is obtained from pepsin-digested antiserum by immunospecific methods of purification.

Immunogen

Purified human IgG

Zastosowanie

Anti-Human IgG (γ-chain specific), F(ab′)2 fragment antibody is suitable for Ouchterlony double diffusion and quantitative precipitin assay. The antibody was used in ELISA and to produce Fab′-oligonucleotide conjugates.

Postać fizyczna

Lyophilized from 0.01 M sodium phosphate, 0.015 M sodium chloride, pH 7.2

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
This page may contain text that has been machine translated.

Nie możesz znaleźć właściwego produktu?  

Wypróbuj nasz Narzędzie selektora produktów.

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 3

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable

Środki ochrony indywidualnej

Eyeshields, Gloves, type N95 (US)

Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

H Brandstätter et al.
Vox sanguinis, 103(3), 201-212 (2012-04-14)
Complement factor H (CFH) acts as major regulator of the alternative pathway of complement and its mutations and polymorphisms predispose to various human diseases. We aimed to develop a scalable purification process of CFH from human plasma fractions to supply
Francesco Lolli et al.
Journal of neuroimmunology, 167(1-2), 131-137 (2005-07-30)
Synthetic glycopeptides have the potential to detect antibodies in multiple sclerosis (MS). In the present study, we analyzed the antibodies (IgM class, IgG class and IgG subclasses) to the synthetic glycopeptide CSF114(Glc) in the serum of 186 MS patients, 166
Hiroyasu Muramatsu et al.
Scientific reports, 11(1), 2160-2160 (2021-01-27)
Myostatin, a member of the transforming growth factor-β superfamily, is an attractive target for muscle disease therapy because of its role as a negative regulator of muscle growth and strength. Here, we describe a novel antibody therapeutic approach that maximizes
Z N Chaudri et al.
FEBS letters, 450(1-2), 23-26 (1999-06-01)
The covalent conjugation of oligonucleotides to antibody Fab' fragments was optimized by using oligonucleotides modified with a hexaethylene linker arm bearing three amino groups. One oligonucleotide was coupled to antibody of one specificity and a complementary oligonucleotide to antibody of
Christian Loch et al.
Journal of pharmaceutical sciences, 103(2), 517-526 (2013-12-07)
Intravitreal injections and drug-loaded implants are current approaches to treat diseases of the posterior eye. To investigate the release of active agents and their distribution in the vitreous body, a new test system was developed that enables a realistic simulation
Wyświetl wszystkie powiązane dokumenty

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej